# 26 Week Open Label Study Evaluating Single IA Injection of DUROLANE SJ for Treatment of Osteoarthritis Pain of the Ankle

> **NCT02627859** · PHASE4 · UNKNOWN · sponsor: **Bioventus LLC** · enrollment: 37 (actual)

## Conditions studied

- Osteoarthritis

## Interventions

- **DEVICE:** Durolane SJ

## Key facts

- **NCT ID:** NCT02627859
- **Lead sponsor:** Bioventus LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-06
- **Primary completion:** 2016-08
- **Final completion:** 2016-10
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2016-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02627859

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02627859, "26 Week Open Label Study Evaluating Single IA Injection of DUROLANE SJ for Treatment of Osteoarthritis Pain of the Ankle". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02627859. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*